Edal, Baby Boy .
HRN: 24-67-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/22/2024
03/29/2024
IV
350mg
Q12
MAS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes